Applied Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Applied Therapeutics, Inc. has filed 529 SEC EDGAR filings since 08 Feb 2017

SEC filing history

Showing 51-75 of 529 matching filings.

Per page
25
Current page
3
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
16 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Jun 2025
Reporting date
15 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
17 Jun 2025
Reporting date
15 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
07 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91017

SCHEDULE 13G filing

Filing date
07 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91017

SCHEDULE 13G filing

Filing date
30 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38898

ARS

Filing date
28 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38898

DEFA14A

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38898

DEF 14A

Filing date
28 Apr 2025
Reporting date
09 Jun 2025
Next action
Verify source filing
S-8 File 333-286731

S-8

Filing date
24 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38898

PRE 14A

Filing date
18 Apr 2025
Reporting date
09 Jun 2025
Next action
Verify source filing
NT 10-K File 001-38898

NT 10-K

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .